RITE
MINERALRITE Corp
$0.003500
0.00%
No data for this timeframe.
Vol
SEC Reports3
Recent Activity
Jun 8, 2026
Insider
Burgauer James acquired via exercise 175 shares
President, CEO @ $120.00 ($21.0K)
Jun 5, 2026
SEC
MineralRite filed an 8-K with Item 4.02 (non-reliance on financial statements), restating its FY2025 10-K and Q1 2026 10
8-K — Impact 7/10
May 7, 2026
SEC
MineralRite disclosed a private transaction where Abstract Concepts 1618 LLC will acquire 6.9M shares of Series NMC Conv
8-K — Impact 4/10
Apr 21, 2026
SEC
MineralRite Corp (RITE) reported key first-quarter developments including renewal of its Arizona mineral lease, field ve
8-K — Impact 4/10
Mar 10, 2026
Insider
Burgauer James acquired via exercise 125 shares
President, CEO @ $120.00 ($15.0K)
Latest Reports
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Jun 8, 2026 | Burgauer James | M | $21.0K |
| Mar 10, 2026 | Burgauer James | M | $15.0K |
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
1 unique insiders with 2 transactions. Net insider value: $0.00 ($0.00 bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 8, 2026 | Burgauer James | President, CEO | EXERCISE | 175 | $120.00 | $21.0K |
| Mar 10, 2026 | Burgauer James | President, CEO | EXERCISE | 125 | $120.00 | $15.0K |
3 SEC filing reports analyzed. Sentiment: 0 bullish, 1 bearish, 0 mixed, 2 neutral. Avg impact: 5.0/10.
BEARISH
8-K
7/10
MineralRite filed an 8-K with Item 4.02 (non-reliance on financial statements), restating its FY2025
Jun 5, 2026
NEUTRAL
8-K
4/10
MineralRite disclosed a private transaction where Abstract Concepts 1618 LLC will acquire 6.9M share
May 7, 2026
NEUTRAL
8-K
4/10
MineralRite Corp (RITE) reported key first-quarter developments including renewal of its Arizona min
Apr 21, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
Recent Reddit Threads
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.